It's the most wonderful time of the year!With the science story tellingAnd everyone dwelling at conferences far and nearIt's the most wonderful time of the year! Summertime is conference season! And as always, our department is being represented at several scientific conferences around the world. From oral and poster presentations to hosting symposia, you can… Continue reading Conference season is here!
Author: psychopharmacologymaastricht
🍫 Like Chocolate? We want you!
New study alert! We are recruiting for a new study assessing habits. We are looking for people who like chocolate and who either do not smoke or smoke at least 10 cigarettes a day. Interested? Email us: d.evans@student.maastrichtuniversity.nl
New study alert! Looking for both users and non-users of cannabis for research into eyewitness memory
New study alert! Looking for both users and non-users of cannabis for research into eyewitness memory. For more information and eligibility check go to https://maastrichtuniversity.eu.qualtrics.com/jfe/form/SV_estjYgegJLrN1jg
Bringing back lost memories
Pim R.A. Heckman, Ph.D. and assistant professor at Maastricht University, as part of a team investigating sleep deprivation and its effects on memory, has recently published a new article suggesting that memories apparently lost because of sleep deprivation are still maintained and can potentially be accessed. Through a combination of optogenetic techniques and the administration… Continue reading Bringing back lost memories
How does 2C-B compare to psilocybin and placebo regarding subjective effects, mood and cognition?
2C-B is a hallucinogenic phenethylamine derived from mescaline. First made by the grand wizard of psychedelic biochemistry Sasha Shulgin in 1974, 2C-B became his favourite of the "magical-half dozen" of substituted phenethylamines. Published in his seminal book PIHKAL, 2C-B promptly reached the wider world of recreational users. However, despite being the most popular 2C-X compound… Continue reading How does 2C-B compare to psilocybin and placebo regarding subjective effects, mood and cognition?